|
⚲
|
| Keyboard |
| Thomas Estok | |
|---|---|
| Firm | |
| Address | c/o Dracen Pharmaceuticals, Inc 780 Third Avenue, 18th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Dracen Pharmaceuticals Inc | 021-420647 | Executive Officer | 8.6 M of 17.0 M |
||
| Adastra Pharmaceuticals Inc | 021-338035 | Director | 2.3 M of 12.0 M |
||
| Dracen Pharmaceuticals Inc | 021-303962 | Executive Officer | 8.5 M of 40.5 M |
||
| Tragara Pharmaceuticals Inc | 021-274520 | Executive Officer | 3.3 M of 5.4 M |
||
| Tragara Pharmaceuticals Inc | 021-246858 | Executive Officer | 13.1 M of 13.1 M |
||
| Tragara Pharmaceuticals Inc | 021-243975 | Executive Officer | 1.2 M of 1.2 M |
||
| Tragara Pharmaceuticals Inc | 021-182388 | Executive Officer | 4.0 M of 6.0 M |
||
| Aarden Pharmaceuticals Inc | 021-151550 | Director | 0.5 M of 0.5 M |
||
| Tragara Pharmaceuticals Inc | 021-98497 | Executive Officer | 5.0 M of 10.0 M |
||